Genentech

Our understanding of multiple sclerosis (MS) continues to evolve rapidly. In our recent episode of Two Scientists Walk Into a Bar, Sherman Jia discusses emerging insights into the underlying biology of MS, including what new research is revealing about disease progression and the potential of next-generation therapies. Explore the latest developments shaping the future of MS research wherever you listen to #podcasts. http://spr.ly/6044B6NYBG

Across many rural communities, including in West Texas, challenges accessing healthcare is a daily reality – from long travel distances and provider shortages to gaps in specialty care. That’s why we convened local providers, patient groups and national partners for a Permian Basin Rural Health Summit where we listened, learned and co-created practical solutions. And this isn’t a one-time conversation. It’s part of our ongoing effort to support long-term, sustainable progress so more people living in rural communities can reliably access the care they need. As healthcare market executive director Donishea Martinez puts it, “We believe that where you live should not determine how long you live.” A huge thanks to our local partners for making this event, and more importantly, efforts to advance a more accessible healthcare system, possible: Texas Tech University Health Sciences Center, Texas Oncology, Odessa Regional Medical Center, Midland Memorial Hospital. Learn more below.

An important milestone has been announced that reinforces our commitment to advancing science for retinal conditions; the FDA has approved an updated label for our treatment for macular edema following retinal vein occlusion (RVO) beyond six months. With this update, we aim to minimize disruptive treatment switches, which can impact long-term visual outcomes for patients. Discover more about this development: http://spr.ly/6045B6I54l

On this day 50 years ago, our co-founders Herb Boyer and Bob Swanson set out to reimagine what medicine could be–and in doing so, they helped launch an entire industry. Today, April 7 is recognized as Biotech Day in California, honoring that legacy. As we mark five decades of innovation, we celebrate the people who’ve carried it forward and those who will shape what comes next. What began as a bold idea has become a legacy defined by curiosity, perseverance and purpose. And we’re just getting started. #TheOriginalBiotech

A vision diagnosis can come with a lot of questions and uncertainty. How we communicate in those moments matters. Hear from ophthalmology leaders on ways to support more clear, thoughtful conversations with patients and caregivers: http://spr.ly/6049B65DY1

MS Awareness Month may have come to a close, but our work with the MS community continues every day. We’re proud to stand alongside the people, families, researchers, and clinicians who continue to push this field forward and inspire what’s possible. As we mark 50 years of scientific discovery, we remain focused on advancing what’s next for people living with MS. #TheOriginalBiotech

Your Story. Our Momentum. Genentech Women Professionals (GWP) is an employee resource group that has supported women at Genentech through professional development, advocacy and community building since 1999. At this year’s annual GWP Summit, we explored how individual leadership journeys fuel collective impact. Timed to Women’s History Month, our 2026 Summit centered on “Purpose, Progress and Possibility,” bringing together employees across career stages to reflect on what it means to grow, lead and innovate in a science- and data-driven organization. Through perspectives from Genentech leaders and external voices, the conversation connected authentic leadership with scientific excellence, highlighting how we navigate complexity, embrace continuous learning and shape the future of biotech. When purpose, progress and possibility come together, we don’t just move forward – we accelerate. #WomensHistoryMonth

Congratulations to Anwesha Dey for being named to the Healthcare Businesswomen's Association's 2026 Class of Rising Stars & Luminaries! As our leader of AI-driven oncology research, Anwesha is not only unlocking new possibilities for treating cancer, she is also a mentor for the next generation of biologists - creating a lasting legacy at Genentech and beyond. Thank you for all you do, Anwesha! Learn more about her story here. http://spr.ly/6042B6mi9O About the Photo: Anwesha (center) pictured with her postdoctoral mentees.

Closing health gaps requires a fundamental shift in how we show up, collaborate and deliver care in local communities. Where you live shouldn’t determine your health — but in Chicago, neighboring communities experience stark disparities in health outcomes and life expectancy. By acting on hyper-local insights and working closely with trusted local institutions, such as The University of Illinois Cancer Center through our Advancing Inclusive Research® Site Alliance and grantee Instituto del Progreso Latino, we’re helping shape healthcare that works for, and with, communities. See how we’re driving impact together, from patient education and inclusive research to workforce development: http://spr.ly/6041B6YFFD

Technology alone doesn't transform an industry; leadership does. In a recent Forbes conversation, Genentech leaders Xingchu Liu, Ph.D., Jacqueline (Jacki) Dioguardi, and Erik Lundgren share how we’ve built a unified data and AI engine supported by a modern digital backbone. From the lab to the clinic, we are industrializing innovation to remove friction from the patient’s path to therapy. Check out the full feature: https://lnkd.in/gfSvc_bJ